TIEGHI, Alessia
 Distribuzione geografica
Continente #
NA - Nord America 659
AS - Asia 317
EU - Europa 211
SA - Sud America 47
AF - Africa 6
Totale 1.240
Nazione #
US - Stati Uniti d'America 635
SG - Singapore 137
CN - Cina 99
DE - Germania 72
BR - Brasile 39
HK - Hong Kong 29
IT - Italia 25
RU - Federazione Russa 23
TR - Turchia 22
GB - Regno Unito 21
UA - Ucraina 20
CA - Canada 17
VN - Vietnam 13
FR - Francia 12
FI - Finlandia 10
SE - Svezia 8
MX - Messico 6
PL - Polonia 6
ZA - Sudafrica 6
AR - Argentina 4
ID - Indonesia 4
IN - India 4
AT - Austria 3
BD - Bangladesh 3
BE - Belgio 3
NL - Olanda 3
CL - Cile 2
JP - Giappone 2
BG - Bulgaria 1
IE - Irlanda 1
IQ - Iraq 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 1.240
Città #
Ashburn 89
Singapore 82
Fairfield 70
Woodbridge 66
Santa Clara 42
Beijing 41
Cambridge 32
Chandler 31
Houston 31
Hong Kong 29
Seattle 29
Los Angeles 20
Wilmington 20
Jacksonville 17
New York 15
Dallas 11
San Diego 10
Shanghai 9
Ann Arbor 8
Munich 8
Falkenstein 7
Montreal 7
Izmir 6
Milan 6
Nanjing 6
Warsaw 6
Addison 5
Fidenza 5
Hanoi 5
Johannesburg 5
London 5
Moscow 5
Princeton 5
Toronto 5
Boardman 4
Boston 4
Dearborn 4
Mexico City 4
Poplar 4
São Paulo 4
Biên Hòa 3
Bremen 3
Brooklyn 3
Brussels 3
Chennai 3
Hefei 3
Manchester 3
Orange 3
Ottawa 3
San Francisco 3
Stockholm 3
Ankara 2
Bologna 2
Buffalo 2
Charlotte 2
Chicago 2
Cincinnati 2
Denver 2
Ferrara 2
Frankfurt am Main 2
Helsinki 2
Ho Chi Minh City 2
Jakarta 2
Jiaxing 2
Jinan 2
Nanchang 2
Nuremberg 2
Orem 2
Rome 2
Tokyo 2
Turku 2
Apodi 1
Arequipa 1
Auburn Hills 1
Auriflama 1
Baghdad 1
Baltimore 1
Barbacena 1
Belo Horizonte 1
Bishkek 1
Brasília 1
Bến Tre 1
Cambira 1
Carney 1
Changsha 1
Charata 1
City of London 1
Clearwater 1
Cleveland 1
College Park 1
Columbus 1
Cormeilles-en-Parisis 1
Criciúma 1
Cuiabá 1
Curitiba 1
Divinolândia 1
Dourados 1
Dublin 1
Glew 1
Grand Rapids 1
Totale 864
Nome #
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 212
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 205
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 193
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 192
Dendritic cells in acute promyelocytic leukaemia 175
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 80
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis 78
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study 64
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib 59
Totale 1.258
Categoria #
all - tutte 5.927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.927


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 7 1 7 0 8 5 2
2021/202275 8 6 6 0 9 3 2 1 1 7 7 25
2022/202372 5 2 5 10 13 9 5 6 13 0 3 1
2023/202444 3 4 0 1 4 9 4 2 2 1 5 9
2024/2025262 6 16 20 16 34 37 10 10 30 19 39 25
2025/2026389 83 31 46 93 121 15 0 0 0 0 0 0
Totale 1.258